| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -95K | 100% | $30.61 | -$2.91M |
| Net | -1 | -95K | -100% | -$2.91M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| MARK L. BAUM | CHIEF EXECUTIVE OFFICER, Director | $141M | 12 Dec 2025 | ||
| Opaleye Management Inc. | 10%+ Owner | $104M | -$2.91M | -2.71% | 09 Jun 2025 |
| ANDREW R. BOLL | President And Cfo | $38.2M | 12 Dec 2025 | ||
| JOHN P. SAHAREK | CEO & President, ImprimisRx | $10.8M | 03 Apr 2025 | ||
| RICHARD L. LINDSTROM MD | Director | $1.02M | 30 Sep 2022 | ||
| Martin A. Makary | Director | $365K | 14 Jun 2024 | ||
| Teresa Sparks | Director | 21 Jun 2023 | |||
| Robert Kammer | Director | 25 Jun 2021 | |||
| R. Lawrence Van Horn | Director | 21 Jun 2023 | |||
| Francis Mullery | CEO, ImprimisRx | 06 Oct 2025 | |||
| LAUREN P. SILVERNAIL | Director | 20 Jun 2025 | |||
| Amir Shojaei | Chief Scientific Officer | 06 Jan 2025 | |||
| Perry J. Sternberg | Director | 20 Jun 2025 | |||
| Randall Pollard | Chief Accounting Officer | 01 Sep 2025 | |||
| Adrienne L. Graves | Director | 20 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|